Table 2.
Changes in levels of norepinephrine (NE) and angiotensin II (AngII) in experimental dogs (control group (n = 20), sham-operated group (n = 19), and RDN group ()).
| Group | NE (pg/ml) | AngII (pg/ml) | Myocardial NE (pg/mg) | Myocardial AngII (pg/mg) |
|---|---|---|---|---|
| Control group | ||||
| Baseline | 123.36 ± 80.16 | 66.48 ± 5.19 | ||
| Preprocedure | 141.13 ± 52.17 | 67.84 ± 8.03 | ||
| 6 months | 180.82 ± 77.03 | 69.33 ± 2.58 | 1953.5 ± 606.7 | 963.0 ± 192.2 |
| Sham-operated group | ||||
| Baseline | 140.16 ± 70.63 | 63.40 ± 8.80 | ||
| Preprocedure | 553.2 ± 202.90ab | 130.40 ± 8.3ab | ||
| 6 months | 609.20 ± 144.36ab | 136.20 ± 6.27ab | 4343.6 ± 346.4b | 1217.1 ± 186.9b |
| RDN group | ||||
| Baseline | 106.12 ± 52.01 | 63.31 ± 7.19 | ||
| Preprocedure | 531.07 ± 159.58ab | 122.74 ± 10.78ab | ||
| 6 months | 299.45 ± 97.08acd | 88.49 ± 5.69acd | 2272.9 ± 774.0c | 1077.8 ± 196.0c |
aCompared with baseline, P < 0.05. bCompared with the control group, P < 0.05. cCompared with the sham-operated group, P < 0.05. dCompared with preprocedure, P < 0.05.